Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00300495 · ClinicalTrials.gov registry record · Phase 3
Study of Amiodarone Given Before Lung Surgery to Prevent Atrial Fibrillation After Lung Resection
A Phase 3 study, sponsored by Beth Israel Deaconess Medical Center.
- Terminated
- Registry status
- Phase 3
- Development phase
- 19
- Enrollment target
NCT00300495: Clinical Trial Phase 3 study, sponsored by Beth Israel Deaconess Medical Center.
NCT00300495 is a Phase 3 study that was terminated before completion, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 19 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00300495, a Phase 3 study, was terminated before completion, sponsored by Beth Israel Deaconess Medical Center.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 19 participants
- Enrollment target
Study Summary
Atrial fibrillation is a very common complication of pulmonary resection. Patients who develop atrial fibrillation require additional treatment and are more likely to stay in the hospital for longer period of time increasing the costs associated with the operation. We propose a randomized controlled trial to see if oral amiodarone given for one week before surgery can prevent atrial fibrillation after pulmonary resection. We plan to evaluate the incidence of atrial fibrillation in patients who received preoperative amiodarone and compare them to the incidence of atrial fibrillation in patients who did not received preoperative amiodarone.
Primary Outcome
Number of patients with post-operative atrial fibrillation
Interventions
- DRUG Amiodarone
- OTHER Control arm, standard care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2006-02 |
| Est. Completion | 2009-10-13 |
| Phase | Phase 3 |
Why NCT00300495 stopped before completion
NCT00300495 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 19 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Amiodarone is the first listed.
NCT00300495 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00300495 about?
NCT00300495 is a clinical study titled "Study of Amiodarone Given Before Lung Surgery to Prevent Atrial Fibrillation After Lung Resection". Atrial fibrillation is a very common complication of pulmonary resection. Patients who develop atrial fibrillation require additional treatment and are more likely to stay in the hospital for longer period of time increasing the costs associated with the operation. We propose a randomized controlled...
What is the current status of trial NCT00300495?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 19 participants. The study started on 2006-02. Estimated completion is 2009-10-13.
What interventions are being tested in trial NCT00300495?
The interventions under investigation include: Amiodarone (DRUG), Control arm, standard care (OTHER).
Who is sponsoring clinical trial NCT00300495?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00300495's enrollment target sits among peer trials
19 1969th of 2000 higher than 31 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03207464 · 19 participants · Phase 1
Molecular Imaging of NET Using [C-11]MRB-PET in MS
- NCT04318717 · 19 participants · Phase 2
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma
- NCT05103904 · 19 participants · Phase 2
Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant
- NCT05607407 · 19 participants · Phase 2
Methimazole in Patients With Progressive Glioblastoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia